Lane & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.09M | Sell |
2,537
-59
| -2% | -$48.7K | 1.13% | 26 |
|
|
2024
Q4 | $2.11M | Sell |
2,596
-65
| -2% | -$52.7K | 1.09% | 26 |
|
|
2024
Q3 | $2.36M | Buy |
2,661
+66
| +3% | +$58.5K | 1.28% | 22 |
|
|
2024
Q2 | $2.35M | Sell |
2,595
-28
| -1% | -$25.4K | 1.39% | 20 |
|
|
2024
Q1 | $2.04M | Hold |
2,623
| – | – | 1.28% | 22 |
|
|
2023
Q4 | $1.53M | Buy |
2,623
+14
| +0.5% | +$8.16K | 1.11% | 25 |
|
|
2023
Q3 | $1.4M | Buy |
2,609
+17
| +0.7% | +$9.13K | 1.13% | 23 |
|
|
2023
Q2 | $1.22M | Sell |
2,592
-7
| -0.3% | -$3.28K | 0.97% | 27 |
|
|
2023
Q1 | $892K | Buy |
2,599
+16
| +0.6% | +$5.49K | 0.8% | 33 |
|
|
2022
Q4 | $945K | Buy |
+2,583
| New | +$945K | 0.9% | 29 |
|